Kang, M.R.; Jo, S.A.; Yoon, Y.D.; Park, K.H.; Oh, S.J.; Yun, J.; Lee, C.W.; Nam, K.-H.; Kim, Y.; Han, S.-B.;
et al. Agelasine D Suppresses RANKL-Induced Osteoclastogenesis via Down-Regulation of c-Fos, NFATc1 and NF-κB. Mar. Drugs 2014, 12, 5643-5656.
https://doi.org/10.3390/md12115643
AMA Style
Kang MR, Jo SA, Yoon YD, Park KH, Oh SJ, Yun J, Lee CW, Nam K-H, Kim Y, Han S-B,
et al. Agelasine D Suppresses RANKL-Induced Osteoclastogenesis via Down-Regulation of c-Fos, NFATc1 and NF-κB. Marine Drugs. 2014; 12(11):5643-5656.
https://doi.org/10.3390/md12115643
Chicago/Turabian Style
Kang, Moo Rim, Sun Ah Jo, Yeo Dae Yoon, Ki Hwan Park, Soo Jin Oh, Jieun Yun, Chang Woo Lee, Ki-Hoan Nam, Youngsoo Kim, Sang-Bae Han,
and et al. 2014. "Agelasine D Suppresses RANKL-Induced Osteoclastogenesis via Down-Regulation of c-Fos, NFATc1 and NF-κB" Marine Drugs 12, no. 11: 5643-5656.
https://doi.org/10.3390/md12115643
APA Style
Kang, M. R., Jo, S. A., Yoon, Y. D., Park, K. H., Oh, S. J., Yun, J., Lee, C. W., Nam, K.-H., Kim, Y., Han, S.-B., Yu, J., Rho, J., & Kang, J. S.
(2014). Agelasine D Suppresses RANKL-Induced Osteoclastogenesis via Down-Regulation of c-Fos, NFATc1 and NF-κB. Marine Drugs, 12(11), 5643-5656.
https://doi.org/10.3390/md12115643